251. Radiomic and Dosiomic Profiling of Paediatric Medulloblastoma Tumours Treated with Intensity Modulated Radiation Therapy
- Author
-
Franco Fusi, Stefano Piffer, Alessandra Retico, Daniela Greto, Piernicola Oliva, Claudio Favre, Stefania Pallotta, Letizia Palumbo, Paolo Dicarolo, Maria Evelina Fantacci, Cinzia Talamonti, Lorenzo Livi, Monica Mangoni, and Antonio Ciccarone
- Subjects
Medulloblastoma ,medicine.medical_specialty ,business.industry ,Radiotherapy unit ,Intensity-modulated radiation therapy ,Precision medicine ,medicine.disease ,Imaging data ,Dosiomic ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,0302 clinical medicine ,Radiomics ,030220 oncology & carcinogenesis ,Medicine ,Profiling (information science) ,Medical physics ,Intensity modulated radiotherapy ,Radiomic ,business - Abstract
The aim of this work is to describe the state of progress of a study developed in the framework of AIM (Artificial Intelligence in Medicine). It is a project funded by INFN, Italy, and it involves researchers from INFN, Hospital Meyer and Radiotherapy Unit of University of Florence. The aim of the proposed study is to apply a retrospective exploratory MR-CT-based radiomics and dosiomic analysis based on emerging machine-learning technologies, to investigate imaging biomarkers of clinical outcomes in paediatric patients affected by medulloblastoma, from images. Features from MR-CT scans will be associated with overall survival, recurrence-free survival, and loco-regional recurrence-free survival after intensity modulated radiotherapy. Dosimetric analysis data will be integrated with the objective of increase predictive value. This approach could have a large impact for precision medicine, as radiomic biomarkers are non-invasive and can be applied to imaging data that are already acquired in clinical settings.
- Published
- 2019